Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2026-06-14 @ 9:13 AM
Study NCT ID:
NCT02187302
Status:
COMPLETED
Last Update Posted:
2020-05-28
First Post:
2014-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)
Sponsor:
Organization: